The Klatskin-Sutker Discovery Fund awards approximately $25,000 annually to one or more primary investigators in the LSI to support specific research in his or her lab. The LSI director and award committee target the award to one or more projects that are scientifically excellent, have potential for high impact on human health, involve collaborative work across disciplines and are unlikely to be funded through traditional grants. 

Examples of the type of research Klatskin-Sutker Discovery Fund could support include:

  • Generation of a novel animal model to emulate a specific disease state
  • Genetic analyses of inherited diseases
  • High-throughput screening of chemical compounds for therapeutic potential against novel targets identified in cancer, neurodegenerative disease and metabolic disorders
  • Evaluation of new uses for old drugs
  • Structural biology studies to generate new insights into functional properties of proteins or potential drugs
  • Analysis of efficacy or side effects of new medicine